% | $
Quotes you view appear here for quick access.


  • marko_ramieus marko_ramieus Apr 14, 2009 8:06 AM Flag

    ACTC news out - relisting to OTC.

    Advanced Cell Technology Moves towards Relisting on Over-the-Counter Bulletin Board

    Company Expects to File 10-Q’s for 2008 Second and Third Quarters Prior to Month-end

    Tuesday April 14, 2009, 8:00 am EDT

    WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC - News) updated the status of its filings for Form 10-Q and 10-K for certain periods during calendar 2008. The Company is in the process of completing its quarterly statements for the periods ended June 30, 2008 and September 30, 2008, and expects to file the 10-Q’s for those periods prior to the end of this month. The Company will then work with its auditors to complete its Form 10-K for the year-ended December 31, 2008. Upon completion, Advanced Cell intends to apply to relist its shares on the Over-the-Counter Bulletin Board.

    “The Company, in conjunction with its auditors, is working diligently to complete the necessary filings in order to relist on the Bulletin Board,” said William Caldwell, CEO of Advanced Cell. “We have made great progress in developing our scientific platform, and are excited to file an IND to commence human clinical trials for our retinal pigment epithelium (RPE) technology. However, we recognize the importance of transparency and believe that a listing on the Bulletin Board will enhance recognition for our Company among the investment community as we believe we have the only technology that can today produce stem cell lines without the destruction of the embryo.”

    About Advanced Cell Technology, Inc.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.73+0.11(+1.66%)May 22 4:00 PMEDT